ImmuniWeb® Discovery vs Ivanti Neurons for EASM: Side-by-Side Comparison (2026)

ImmuniWeb® Discovery: ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web. built by ImmuniWeb. Core capabilities include Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring..

Ivanti Neurons for EASM: Cloud-based EASM platform for discovering internet-facing assets & exposures. built by Ivanti. Core capabilities include Agentless monitoring for internet-facing asset discovery, Continuous near-real-time asset visibility, Vulnerability Risk Score (VRS) for CVE prioritization..

Both serve the External Attack Surface Management market but differ in approach, feature depth, and target audience.

ImmuniWeb® Discovery differentiates with Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring. Ivanti Neurons for EASM differentiates with Agentless monitoring for internet-facing asset discovery, Continuous near-real-time asset visibility, Vulnerability Risk Score (VRS) for CVE prioritization.

ImmuniWeb® Discovery is developed by ImmuniWeb. Ivanti Neurons for EASM is developed by Ivanti. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

ImmuniWeb® Discovery and Ivanti Neurons for EASM serve similar External Attack Surface Management use cases: both are External Attack Surface Management tools. Review the feature comparison above to determine which fits your requirements.